We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+1.33%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9M
AUM Growth
-$920K
Cap. Flow
-$809M
Cap. Flow %
-3,698.27%
Top 10 Hldgs %
16.04%
Holding
3,383
New
122
Increased
1,094
Reduced
1,082
Closed
180

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$102M
2
CSCO icon
Cisco
CSCO
+$72.8M
3
COR icon
Cencora
COR
+$60.9M
4
MRK icon
Merck
MRK
+$52.9M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$48.4M

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$132M
2
CBRE icon
CBRE Group
CBRE
+$86M
3
PPLI
People Inc
PPLI
+$72M
4
PFE icon
Pfizer
PFE
+$67.2M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$54.4M

Sector Composition

Rank Sector Weight
1 Technology 16.85%
2 Healthcare 12.72%
3 Financials 12.47%
4 Industrials 10.15%
5 Consumer Discretionary 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYI icon
1376
Acuity Brands
AYI
$10.3B
$49 ﹤0.01%
364
+285
+361% +$37.1K
CHIQ icon
1377
Global X MSCI China Consumer Discretionary ETF
CHIQ
$128M
$49 ﹤0.01%
3,080
IGRO icon
1378
iShares International Dividend Growth ETF
IGRO
$1.29B
$49 ﹤0.01%
899
PBW icon
1379
Invesco WilderHill Clean Energy ETF
PBW
$394M
$49 ﹤0.01%
1,701
CHEF icon
1380
Chefs' Warehouse
CHEF
$4.09B
$48 ﹤0.01%
1,200
+109
+10% +$4.08K
KIM icon
1381
Kimco Realty
KIM
$17.7B
$48 ﹤0.01%
2,300
+860
+60% +$16.4K
CNH
1382
CNH Industrial
CNH
$14.2B
$48 ﹤0.01%
5,450
+101
+2% +$888
AIMT
1383
DELISTED
Aimmune Therapeutics
AIMT
$48 ﹤0.01%
2,337
+347
+17% +$7.08K
ELME
1384
Elme Communities
ELME
$142M
$47 ﹤0.01%
1,728
-78
-4% -$2.11K
NKTR icon
1385
Nektar Therapeutics
NKTR
$2.39B
$47 ﹤0.01%
176
NTES icon
1386
NetEase
NTES
$81.5B
$47 ﹤0.01%
895
-270
-23% -$13.7K
RSPD icon
1387
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$321M
$47 ﹤0.01%
1,350
GBT
1388
DELISTED
Global Blood Therapeutics, Inc.
GBT
$47 ﹤0.01%
973
+400
+70% +$20.8K
INAP
1389
DELISTED
Internap Corporation
INAP
$47 ﹤0.01%
18,300
+10,325
+129% +$27K
CBM
1390
DELISTED
Cambrex Corporation
CBM
$47 ﹤0.01%
804
-635,818
-100% -$34M
VISN
1391
Vistance Networks Inc
VISN
$2.67B
$46 ﹤0.01%
4,059
MAIN icon
1392
Main Street Capital
MAIN
$5.14B
$46 ﹤0.01%
1,070
RDY icon
1393
Dr. Reddy's Laboratories
RDY
$9.77B
$46 ﹤0.01%
6,180
+1,665
+37% +$12.4K
VOOG icon
1394
Vanguard S&P 500 Growth ETF
VOOG
$25.2B
$46 ﹤0.01%
1,722
ALTR
1395
DELISTED
Altair Engineering Inc
ALTR
$46 ﹤0.01%
+1,350
New +$50.3K
GWB
1396
DELISTED
Great Western Bancorp, Inc.
GWB
$46 ﹤0.01%
1,431
+8
+0.6% +$258
AMD icon
1397
Advanced Micro Devices
AMD
$741B
$45 ﹤0.01%
1,608
-137
-8% -$4.3K
AVAL icon
1398
Grupo Aval
AVAL
$5.79B
$45 ﹤0.01%
6,147
-353
-5% -$2.68K
BL icon
1399
BlackLine
BL
$1.87B
$45 ﹤0.01%
960
+75
+8% +$3.73K
FHI icon
1400
Federated Hermes
FHI
$4.59B
$45 ﹤0.01%
1,411
+43
+3% +$1.41K

Similar funds

Glenmede Trust's Q3 2019 Portfolio in Review

As of Q3 2019, Glenmede Trust held 3,383 positions worth $21.9M, down 4% from $22.8M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust withdrew a net $809M in Q3 2019, closing 180 positions and reducing 1,082 holdings. Its most notable exit was Callon Petroleum Company, an estimated $21.9K position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Carlisle Companies worth $31K.

  • Glenmede Trust's largest Q3 2019 buy was Carlisle Companies: 212,908 shares worth $31K.
  • Glenmede Trust added most to American Tower in Q3 2019, an estimated $102M increase.
  • Glenmede Trust's biggest Q3 2019 reduction was Boeing, cutting an estimated $132M.
  • Glenmede Trust fully exited Callon Petroleum Company in Q3 2019, selling an estimated $21.9K.
  • Glenmede Trust's ten largest holdings make up 16% of its $21.9M portfolio in Q3 2019.
  • Glenmede Trust opened 122 new positions and closed 180 in Q3 2019.
  • Glenmede Trust's portfolio value fell 4% quarter-over-quarter to $21.9M.

Based on Glenmede Trust's 13F filing for Q3 2019, filed 14 Nov 2019.